Is AN2 Therapeutics, Inc. (ANTX) a Buy, Sell, or Hold?
NASDAQ : ANTX
AN2 Therapeutics, Inc.
$4.745 USD
$0.07 (1.61%)
- Volume
- 25.11K
- Average Volume
- 310.61K
- Market Capitalization
- $130.02M
- P/E Ratio
- -4.31
- Dividend Yield
- 0.00%
- Price Target
- $9.00
- Year High
- $6.91
- Year Low
- $1.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.73
ANTX vs. The Competition
| Properties | ANTX | BOLD | IBIO | INTS |
|---|---|---|---|---|
| Market Cap | $130.02M | $55.74M | $21.63M | $8.64M |
| Shares Outstanding | $27.4M | $22.47M | $15.79M | $1.89M |
| P/E Ratio | -4.31 | -0.99 | -2.38 | -0.66 |
| EPS | -1.01 | -2.5 | -0.23 | -0.42 |
| Day Low | 4.635 | 2.45 | 1.31 | 4.57 |
| Day High | 4.81 | 2.5 | 1.395 | 4.8 |
| Year Low | 1 | 0.961 | 0.56 | 3.51 |
| Year High | 6.91 | 2.79 | 3.82 | 43.5 |
| Average Price 50 | 4.592 | 1.8082 | 1.6656 | 4.40624 |
| Average Price 200 | 2.59938 | 1.3809 | 1.7914 | 7.51118 |
| Volume | 25113 | 36818 | 175.66K | 4419.21 |
| Average Volume | - | - | - | - |